Literature DB >> 33875775

A survival analysis of surgically treated incidental low-grade glioma patients.

Lingcheng Zeng1, Qi Mei2, Hua Li3, Changshu Ke4, Jiasheng Yu3, Jian Chen3.   

Abstract

To evaluate the surgical effect on survival in patients with incidental low-grade glioma (LGG) through comparison between asymptomatic and symptomatic patients. The medical records of surgically treated adult cerebral incidental LGG (iLGG) patients in our department between January 2008 and December 2015 were retrospectively reviewed. The survival of patients was calculated starting from the initial imaging diagnosis. Factors related to progression-free survival (PFS), overall survival (OS) and malignant progression-free survival (MPFS) were statistically analyzed. Seventy-five iLGG patients underwent surgery: 49 in the asymptomatic group, who underwent surgery in the asymptomatic period, and 26 in the symptomatic group, who underwent surgery after the tumor had grown and the patients had developed tumor-related symptoms. Significantly more tumors were initially located adjacent to the functional area in the symptomatic group than in the asymptomatic group (P < 0.05), but there was no significant difference in the total resection rate between the two groups. The incidence of postoperative complications (15.4%) and postoperative epilepsy (23.1%) was higher in the symptomatic group than in the asymptomatic group (4.1% and 10.2%, respectively). Multivariate analysis showed that surgical timing, namely, surgery performed before or after symptom occurrence, had no significant effect on PFS, OS or MPFS, while total resection significantly prolonged PFS, OS and MPFS, and the pathology of oligodendroglioma was positively correlated with PFS and OS (P < 0.05). Surgical timing for iLGGs should facilitate total resection. If total resection can be achieved, even after symptom occurrence, patients can achieve comparable survival benefits to those treated with surgery in the asymptomatic phase.

Entities:  

Year:  2021        PMID: 33875775     DOI: 10.1038/s41598-021-88023-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  2 in total

1.  Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis.

Authors:  Zhen-Yu Zhang; Aden Ka-Yin Chan; Ho-Keung Ng; Xiao-Jie Ding; Yan-Xi Li; Zhi-Feng Shi; Wei Zhu; Ping Zhong; Yin Wang; Ying Mao; Yu Yao; Liang-Fu Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01
  2 in total
  5 in total

Review 1.  Surveillance imaging frequency in adult patients with lower-grade (WHO Grade 2 and 3) gliomas.

Authors:  Jasmin Jo; Martin J van den Bent; Burt Nabors; Patrick Y Wen; David Schiff
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

Review 2.  Systematic review-Time to malignant transformation in low-grade gliomas: Predicting a catastrophic event with clinical, neuroimaging, and molecular markers.

Authors:  Zabina Satar; Gary Hotton; George Samandouras
Journal:  Neurooncol Adv       Date:  2021-07-27

3.  Malignant Progression of Diffuse Low-grade Gliomas: A Systematic Review and Meta-analysis on Incidence and Related Factors.

Authors:  Satoshi Nakasu; Yoko Nakasu
Journal:  Neurol Med Chir (Tokyo)       Date:  2022-02-22       Impact factor: 2.036

Review 4.  Brain Gliomas and Ollier Disease: Molecular Findings as Predictive Risk Factors?

Authors:  Sergio Corvino; Giuseppe Mariniello; Giuseppe Corazzelli; Raduan Ahmed Franca; Marialaura Del Basso De Caro; Rosa Della Monica; Lorenzo Chiariotti; Francesco Maiuri
Journal:  Cancers (Basel)       Date:  2022-07-16       Impact factor: 6.575

Review 5.  Modern surgical management of incidental gliomas.

Authors:  Anjali Pradhan; Khashayar Mozaffari; Farinaz Ghodrati; Richard G Everson; Isaac Yang
Journal:  J Neurooncol       Date:  2022-06-15       Impact factor: 4.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.